A Viewpoint published by the JAMA Network on December 15, 2021, highlights how dengue disease has become an increasing risk in various countries.
Furthermore, as the Aedes species mosquito vector reaches into new areas, the risk for large outbreaks in U.S. territories and gateway states increases daily as international travelers return from endemic regions.
These researchers say, ‘Clinicians should become familiar with practical dengue prevention tools such as vaccines.’
Dengue Vaccination Enters a New Age
100-Year-Old Vaccine Keeps on Protecting
A long, long time ago, the Bacillus Calmette-Guerin (BCG) vaccine was approved for use against tuberculosis (TB).
For generations, the BCG vaccine was given to infants to save lives.
The problem is that the BCG vaccine was the first—and the last—vaccine approved to prevent tuberculosis.
And yet, TB still kills around 1.5 million people every year.